WEBINAR: After COVID-19, will there be an even more devastating AMR outbreak?
The online event will look at the requirement for a new business model for the development, production and sales of new antibiotics.
4 June 2020, 12:00-13:00 CET
A Joint Parliament Magazine/PA International Multi-stakeholder Webinar
Never waste a good crisis: Covid-19 has demonstrated Europe is not at all prepared for pandemics. After decades of mismanagement of the relations with China the EU’s almost total dependency on China and India for many pharmaceuticals and other medical supplies is as evident. What must now be prioritised? How must a shared combating AMR goal be realised?
The UK’s top adviser on Antimicrobial Resistance and former Conservative Finance Secretary and Goldman Sachs banker Lord Jim O’Neill will table shockingly new but possibly unavoidable solutions. Among the key arguments: our market and even system demonstrates a fatal flaw soon costing more lives than cancer or car accidents: 300 million by 2050!
Mr Tiemo Wölken (S&D, Germany) Vice-Chair of the MEP Interest Group on AMR will introduce the European Parliament’s most critical concerns and options. Pre-competitive and scientific options will be delivered by Dr Jon de Vlieger (European Lead Factory/Lygature Foundation, Netherlands), Dr Marc Gitzinger (Vice-President of the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance and CEO of BioVersys) and Dr Jean-Paul Pirnay (Queen Astrid Military Hospital, Belgium). Senior representatives of DG RTD and DG SANTE have been invited to attend.
This content is published by the Parliament Magazine on behalf of our partners.
No one likes to talk about salmonella in feed, but the consequences of the recent formaldehyde denial mean we will be forced to talk about it a whole lot more, warns Phil McGuire.
Unlike human medicines veterinary medicines undergo a thorough environmental risk assessment, explains AnimalhealthEurope Secretary General, Roxane Feller.
As the world looks to Europe to lead on evidence-based decision-making, we must not let politics trump science, warns Nathalie Moll.